NCT03041285 2022-05-11
Idronoxil Suppository Combine With Radiotherapy for Metastatic Prostate Cancer
Royal North Shore Hospital
Phase 1 Terminated
Clinical Trials
7 trialsNCT02941523 2021-06-02
Safety, PK and Efficacy of NOX66 as a Monotherapy and Combined With Carboplatin in Refractory Solid Tumours
Noxopharm Limited
Phase 1/2 Completed
NCT00303888 2018-01-17
Docetaxel With or Without Phenoxodiol in Treating Patients With Recurrent Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer
Yale University
Phase 1 Terminated
NCT00382811 2016-07-18
OVATURE
MEI Pharma, Inc.
Phase 3 Completed
NCT00091377 2016-07-14
Phenoxodiol Combined With Either Cisplatin or Paclitaxel in Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
MEI Pharma, Inc.
Phase 1/2 Completed
NCT00022295 2013-03-26
Phenoxodiol in Treating Patients With Refractory Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT00557037 2010-04-08
A Phase II Trial of Phenoxodiol in Patients With Castrate and Non-Castrate Prostate Cancer
MEI Pharma, Inc.
Phase 2 Completed